Does IDARUCIZUMAB Cause Activated partial thromboplastin time prolonged? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Activated partial thromboplastin time prolonged have been filed in association with IDARUCIZUMAB (Praxbind). This represents 1.3% of all adverse event reports for IDARUCIZUMAB.
20
Reports of Activated partial thromboplastin time prolonged with IDARUCIZUMAB
1.3%
of all IDARUCIZUMAB reports
10
Deaths
9
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From IDARUCIZUMAB?
Of the 20 reports, 10 (50.0%) resulted in death, 9 (45.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDARUCIZUMAB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does IDARUCIZUMAB Cause?
Death (170)
Haemorrhage (110)
Cerebral haemorrhage (92)
Gastrointestinal haemorrhage (83)
Haemorrhage intracranial (68)
Multiple organ dysfunction syndrome (68)
Drug ineffective (58)
Pneumonia (51)
Acute kidney injury (49)
Cerebral infarction (46)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which IDARUCIZUMAB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
IDARUCIZUMAB vs IDECABTAGENE VICLEUCEL
IDARUCIZUMAB vs IDELALISIB
IDARUCIZUMAB vs IDURSULFASE
IDARUCIZUMAB vs IFOSFAMIDE
IDARUCIZUMAB vs IGURATIMOD